Shared on 06 Sep 25

With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.

Read more

0 votesShare

Shared on 01 May 25

Fair value Decreased 11%

Read more

0 votesShare

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 17 Apr 25

Fair value Decreased 0.66%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 02 Apr 25

Fair value Decreased 0.55%

AnalystConsensusTarget has decreased profit margin from 9.8% to 7.3% and increased future PE multiple from 15.9x to 21.3x.

Read more

0 votesShare

Shared on 26 Mar 25

Fair value Decreased 1.20%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 19 Mar 25

Fair value Increased 8.12%

AnalystConsensusTarget has decreased profit margin from 11.8% to 9.9% and increased future PE multiple from 13.9x to 16.1x.

Read more

0 votesShare